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Identification and characterization of DdPDE3, a cGMP-selective
phosphodiesterase from Dictyostelium
Hidekazu KUWAYAMA1, Helena SNIPPE, Mari DERKS, Jeroen ROELOFS and Peter J. M. VAN HAASTERT2
*GBB, Department of Biochemistry, University of Groningen, Nijenborgh 4, 9747 AG Groningen, The Netherlands
In Dictyostelium cAMP and cGMP have important functions as
first and second messengers in chemotaxis and development.
Two cyclic-nucleotide phosphodiesterases (DdPDE 1 and 2)
have been identified previously, an extracellular dual-specificity
enzyme and an intracellular cAMP-specific enzyme (encoded
by the psdA and regA genes respectively). Biochemical data
suggest the presence of at least one cGMP-specific phospho-
diesterase (PDE) that is activated by cGMP.Using bioinformatics
we identified a partial sequence in the Dictyostelium expressed
sequence tag database that shows a high degree of amino
acid sequence identity with mammalian PDE catalytic domains
(DdPDE3). The deduced amino acid sequence of a full-length
DdPDE3 cDNA isolated in this study predicts a 60 kDa protein
with a 300-residue C-terminal PDE catalytic domain, which is
preceded by approx. 200 residues rich in asparagine and glu-
tamine residues. Expression of the DdPDE3 catalytic domain in
INTRODUCTION
Eukaryotes are endowed with a large family of cyclic-nucleotide
phosphodiesterase (PDE ) genes [1–3]. The deduced amino acid
sequences share a common element of approx. 300 amino
acid residues that forms the catalytic domain. Some enzymes
specifically hydrolyse cAMP (PDE4, PDE7 and PDE8) or cGMP
(PDE5, PDE6 and PDE9), whereas other enzymes show dual
specificity. Besides the putative catalytic domain, many enzymes
possess additional domains that provide regulation by cal-
modulin (PDE1) or cGMP, which can be stimulatory (PDE2 or
PDE5) or inhibitory (PDE3). The enzymic activities of PDEs
might simply serve to degrade cAMP and cGMP. However, the
complexity of the PDE superfamily provides the potential for
additional regulatory circuits. For instance, the activation of
guanylate cyclase and the accompanying increase in cGMP levels
might indirectly alter the levels of cAMP, which will decrease
when cAMP is hydrolysed mainly by a cGMP-stimulated cAMP-
PDE and will increase when cAMP is hydrolysed by a dual-
specificity enzyme that is subject to competitive inhibition by the
increased cGMP levels.
In Dictyostelium, cAMP and cGMP have pronounced roles as
first and second messengers [4,5]. Dictyostelium grows as single
cells in the soil, feeding on bacteria. During this stage of the life
cycle, cAMP and cGMP are probably not essential for growth.
However, cyclic nucleotides are important when cells are starved.
Depletion of the food source induces a developmental pro-
gramme, leading to a multicellular stage. An extracellular cAMP
signalling system is induced that is composed of the adenylate
cyclase ACA, the G-protein-coupled cAMP surface receptor
Abbreviations used: 8Br-cGMP, 8-bromoguanosine 3«,5«-monophosphate ; CIP, calf intestine alkaline phosphatase ; EST, expressed sequence tag;
IBMX, 3-isobutyl-1-methylxanthine ; PDE, phosphodiesterase.
1 Present address : Institute of Biological Sciences, University of Tsukuba, Tsukuba, Ibaraki 305-8572, Japan.
2 To whom correspondence should be addressed (e-mail p.j.m.van.haastert!chem.rug.nl).
Escherichia coli shows that the enzyme has Michaelis–Menten
kinetics and a higher affinity for cGMP (K
m
fl 0.22 lM) than for
cAMP (K
m
fl 145 lM); cGMP does not stimulate enzyme ac-
tivity. The enzyme requires bivalent cations for activity ; Mn#+
is preferred to Mg#+, whereas Ca#+ yields no activity. DdPDE3 is
inhibited by 3-isobutyl-1-methylxanthine with an IC
&!
of approx.
60 lM. Overexpression of the DdPDE3 catalytic domain in
Dictyostelium confirms these kinetic properties without indi-
cations of its activation by cGMP. The properties of DdPDE3
resemble those of mammalian PDE9, which also shows the
highest sequence similarity within the catalytic domains.
DdPDE3 is the first cGMP-selective PDE identified in lower
eukaryotes.
Key words: chemotaxis, cloning, guanylate cyclase, mutant stmF.
cAR1, and specific G-protein subunits. This signalling system
produces extracellular cAMP that actually accumulates and
disappears in an oscillatory manner. Degradation of cAMP by a
PDE that is present in the extracellular medium and on the cell
surface is essential to the generation of such cAMP pulses [6,7].
Extracellular cAMP induces chemotaxis : starving cells move
towards the source of cAMP, thereby forming a slug-shaped
multicellular structure. In this slug, cell differentiation towards
pre-stalk and pre-spore cells takes place, finally leading to a
fruiting body composed of a stalk tube supporting a droplet of
spores. Intracellular cAMP is essential for pre-spore differen-
tiation. It is synthesized by the G-protein-coupled adenylate
cyclase ACA [8], and by a G-protein-independent enzyme ACB
[9] encoded by the acrA gene [10]. Intracellular cAMP is degraded
predominantly by a cAMP-specific enzyme encoded by the regA
gene [11,12].
During cell aggregation, extracellular cAMP induces a rapid
transient increase in cGMP levels [5]. This nucleotide is produced
by a guanylate cyclase that is presumably directly activated by G-
proteins. In cell lysates, cGMP is degraded predominantly by
a cGMP-specific enzyme that is activated by cGMP [13–15]. The
cGMP-stimulated cGMP-PDE activity from Dictyostelium is
absent from stmF mutant NP368, which is characterized by
prolonged chemotactic movement [14,16,17]. In this mutant, the
cAMP-stimulated cGMP accumulation proceeds for a longer
period, reaches higher concentrations and recovery of basal
levels is retarded approx. 6-fold. Quantitative analysis of these
data indicates that the cGMP-PDE that is absent from stmF
accounts for approx. 80% of the cGMP hydrolysis in wild-type
cells and another unidentified enzyme for approx. 20% [18].
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To characterize further the role of cGMP in Dictyostelium
chemotaxis, we have started to clone the genes that encode the
enzymes synthesizing or degrading intracellular cGMP. The
Dictyostelium sequencing project in Japan [19] provided a partial
cDNA sequence encoding an amino acid sequence that exhibited
a significant degree of identity with the catalytic domain of
mammalian PDEs. We obtained a full-length sequence for this
DdPDE3, and expressed the protein in Escherichia coli and
Dictyostelium. DdPDE3 seems to degrade cGMP specifically but
the enzyme is not activated by cGMP and is still present in
mutant stmF. This suggests that DdPDE3 represents the residual
cGMP-hydrolysing activity in mutant stmF.
MATERIALS AND METHODS
Materials
[2,8-$H]cAMP (1.85 Bq}mmol) and [8-$H]cGMP (0.55 Bq}
mmol) were obtained from Amersham; cAMP, cGMP, 8-
bromoguanosine 3«,5«-monophosphate (8Br-cGMP), calf
intestine alkaline phosphatase (CIP) and IPTG (isopropyl b-d-
thiogalactoside) were purchased from Boehringer Mannheim.
3-Isobutyl-1-methylxanthine (IBMX) was obtained from Cal-
biochem; pRSET came from Invitrogen.
Strain and culture conditions
Dictyostelium AX3 (‘wild-type’), PDE3 cells overexpressing
DdPDE3, and A"&-D5«GCA}PDE3 cells overexpressing both
DdGCA and DdPDE3, were grown in HG5 medium (HL5
medium with 10 g}litre glucose). When growing cells under
selection, HG5 medium was supplemented with 10 lg}ml blast-
icidine S or 10 lg}ml geneticin (neomycin), depending on the
selection marker present (blasticidine deaminase and neomycin
phosphotransferase genes respectively). StmF mutant NP368 and
its isogenic parental strain XP55 were grown in association with
Klebsiella aerogenes. Cells were starved for up to 5 h by being
shaken in 10 mM phosphate buffer, pH 6.5, at a density of 10(
cells}ml for the indicated durations. For longer starvation
periods, cells were transferred to non-nutrient agar plates [1.5%
(w}v) agar in 10 mM phosphate buffer, pH 6.5] and incubated at
22 °C. For DNA transfection by electroporation, cells were
grown to exponential phase at a density of (1–3)‹10’ cells}ml.
Approximately 10( cells were mixed with 1–10 lg of DNA. After
electroporation [20] and 5 h of recovery in a 10 cm dish, selection
medium was added. Medium was changed after 24 h for the first
time and thereafter approximately every 3 days.
Cloning of DdPDE3
The expressed sequence tag (EST) clone SSB116 was identified as
a potential PDE-encoding sequence in the Japanese cDNA
project by using bioinformatics. The clone was kindly provided
by Dr T. Morio [19] and sequenced completely. The insert was
used as a probe to screen a kZAP cDNA library kindly provided
by Dr R. A. Firtel. In a screen of 10’ clones, 21 positive clones
were identified. Inserts from 14 clones were rescued as Bluescript
plasmids, with insert sizes from 1.2 to 1.9 kb. LambdaZAP clone
116-6 had the largest insert and was sequenced completely.
Northern and Southern analysis
RNA was isolated from 3‹10( cells at the indicated devel-
opmental stage with the Qiagen Rneasy minikit by using the
supplier’s protocol for animal cells. After separation of the RNA
samples on a formaldehyde}1% (w}v) agarose gel, the samples
were transferred to a Nytran filter (Schleicher & Schuell).
Genomic DNA was purified with a minipreparation as described
in [21]. Approximately 0.25 lg of genomic DNA was digested
with the indicated restriction enzymes, separated on a 0.7%
agarose gel and transferred to a Nytran filter. Northern and
Southern blotswere preincubated for 2 h at 65 °C inhybridization
solution [0.5 M sodium phosphate buffer (pH 7.0)}7% (w}v)
SDS}0.2 mg}ml BSA]. Hybridization was performed in the same
prehybridization solution with the addition of a radioactive
probe. Probes were labelled with $#P by the random primer
method (High Prime; Boehringer Mannheim). Blots were incu-
bated for 16 h, washed at high stringency with wash solution 1
[0.5M phosphate buffer}1% (w}v) SDS (pH 7.0) at 65 °C] and
wash solution 2 [0.1 M phosphate buffer}1% (w}v) SDS (pH 7.0)
at 65 °C] and exposed with a PhosphorImager.
Expression of DdPDE3 catalytic domain in E. coli
A 0.9 kb region of cDNA 116-6 starting at bp 888 was amplified
by PCR with the universal sequencing primer as the 3« primer
and the gene-specific 5« primer 5«-ATCATGGATCCAAAA-
TGCGTGGTTATAATGATAATAATG-3« ; a BamHI restriction
site is underlined; the DdPDE3 sequence is indicated in bold.
The PCR product was digested with BamHI and KpnI and
subcloned in pUC21, yielding pUC21-PDE3. After sequencing,
the BamHI}KpnI insert was ligated into the BamHI and KpnI
sites of the bacterial expression plasmid pRSET-A, yielding
pRSET-PDE3. The encoded protein lacks the first 201 residues
of DdPDE3 consisting of the glutamine and asparagine repeats.
Translation starts with the amino acid sequence MASMTGG-
QQMGRGSKM (single-letter codes) derived from pRSET and
the 5« region of the PCR primer. It continues with the DdPDE3-
derived amino acid sequence starting with R#!&GYNDNN, which
is approx. 35 amino acids before the start of the conserved
catalytic domain.
Plasmid pRSET-PDE3 was used to transform E. coli
BL21DE3. Bacteria were grown overnight at 37 °C in Luria–
Bertani medium containing 25 lg}ml ampicillin and 50 lg}ml
chloramphenicol. The culture was then diluted 1:40 in the same
medium. After growth for 2 h at 30 °C, 25 lg}ml IPTG was
added and growth was continued for 3 h at 30 °C. A 10 ml
aliquot of the culture was centrifuged for 5 min at 3000 g, the
pellet was resuspended in 15 ml of ice-cold PDE buffer [20 mM
Hepes}NaOH}1 mM MgCl
#
(pH 7.0)] and cells were lysed by
sonication with four pulses of 3 s each. PDE activity was
measured in the crude lysate ; the activity was stable for several
months when the lysate was stored at fi80 °C.
Expression of DdPDE3 catalytic domain in Dictyostelium
The BamHI}XbaI insert of pUC21-PDE3 was ligated into the
BglII}SpeI sites of the Dictyostelium expression plasmid HK12N,
yielding HK12N-PDE3. The plasmid HK12N is a derivative of
the extrachromosomal plasmid MB12N [22], with a small mul-
tiple cloning site in the original BglII site that allows the
directional ligation of genes to be expressed. Translation from
HK12N-PDE3 starts with the first ATG codon after the BamHI
site of the PCR primer; after translation the start methionine is
followed by the DdPDE3-specific sequence beginning with the
motif R#!&GYNDNN.
HK12N-PDE3 was used to transform Dictyostelium wild-type
strain AX3 and strain A"&-D5«GCA-neo, which overexpresses a
guanylate cyclase under G418 selection (J. Roelofs, H. Snippe,
R. G. Kleineidam and P. J. M. Van Haastert, unpublished work).
Transformants were selected in HG5 medium in the presence of
10 lg}ml blasticidine. Cells were grown at 22 °C to a density of
3‹10’ cells}ml, washed in 10 mM phosphate buffer, pH 6.5, and
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Figure 1 Scheme and composite sequence of DdPDE3
Top panel : scheme of DdPDE3. The coding region is shown as a box ; the 5«and 3« untranslated
regions are depicted as lines. The putative catalytic domain is shown hatched and the stretches
of polyglutamine and polyasparagine are indicated as Q and N respectively. The upper numbers
refer to amino acids ; the lower numbers indicate nucleotides. Southern blot analysis with the
indicated restriction sites Sca I and Bgl II revealed the predicted 1.7 kb fragment. Lower panel :
starved for 1 h in 10 mM phosphate buffer, pH 6.5, at a density
of 10( cells}ml. Cells were washed and resuspended in ice-cold
lysis buffer [20 mM Hepes}NaOH}1 mM EGTA (pH 7.0)] to
a density of 10) cells}ml, then lysed by forced filtration through a
Nucleopore filter (pore size 0.45 lm). The lysate was centrifuged
for 5 min at 14000 g ; the supernatant was used in the PDE
assays.
Assays for PDE, cGMP response and chemotaxis
PDE activity was assayed in mixtures of 100 ll containing PDE
buffer [20 mM Hepes}NaOH}1 mM MgCl
#
(pH 7.0)], 10 nM
[$H]cAMP or [$H]cGMP, unlabelled cAMP or cGMP as indi-
cated, and 30 ll of enzyme (diluted lysates from E. coli or Dicty-
ostelium to achieve between 10 and 30% hydrolysis). The
reactions were conducted at 22 °C for 15 min, terminated by
boiling for 1 min, and followed by dephosphorylation of the
hydrolytic product with phosphatase (1 h incubation at 37 °C
with 100 ll of CIP buffer containing 1 unit of CIP). Finally,
500 ll of a 50% (w}v) slurry of DOWEX AG1‹2 was added,
samples were incubated for 15 min at 22 °C, centrifuged for
2 min at 14000 g, and the radioactivity in 250 ll of the super-
natant was determined.
For measurement of the cGMP response, cells were starved for
5 h, washed and then resuspended in 10 mM phosphate buffer,
pH 6.5, to a density of 10) cells}ml. Cells were stimulated with
0.1 lM cAMP; at the times indicated, samples of the cell
suspension were added to an equal volume of 3.5% (w}v)
HClO
%
. The cGMP content was measured with a radio-
immunoassay in these lysates after neutralization with KHCO
$
[23]. Chemotaxis towards cAMP and folic acid was measured by
the small-population assay [24].
RESULTS
Cloning of DdPDE3
Two stretches of amino acids that are conserved in the putative
catalytic domain of mammalian PDEs were used to search
for similar sequences in the Dictyostelium cDNA database,
HDyDHpGTtNqFlVntKSeLAlLYndESVMEnHH and DLSn-
pTKplplyRrwAELImeEFFxQGDkEKeMG. In these peptide
sequences, capital letters show residues that were kept constant,
while at the positions of lower case letters conservative substi-
tutions or other amino acids found frequently in PDEs were
accepted. With thismethod we identified a 0.7 kb cDNA, SSB116,
that had been partly sequenced. Its deduced amino acid sequence
showed a moderate degree of sequence identity with a small part
of mammalian PDE enzymes. We determined the complete
nucleotide sequence of this 0.7 kb cDNA, which seemed to
encode a complete putative PDE catalytic domain. Because the
cDNA hybridizes to an mRNA of approx. 1.9 kb (see below),
the missing 1.2 kb sequence might encode regulatory domains.
Therefore a complete cDNA (clone 116-6) was isolated from a
kZAP cDNA library.
The kZAP cDNA 116-6 is 1882 bp in length. At its 3« end the
complete nucleotide and deduced amino acid sequence. The basis of the sequence, including
the 5« and 3« ends, was cDNA clone 116-6, which was verified and extended by sequences
from the Dictyostelium database by using three cDNA clones and nine genomic clones that
collectively spanned the complete sequence, revealing two introns in the putative catalytic
domain. The protein sequence is shown in single-letter code below the nucleotide sequence.
Nucleotide and protein numberings are presented at the right and left respectively. Numbering
of the protein starts at the first methionine ; a second in-frame methionine residue is found at
position 8.
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Figure 2 Alignment of the catalytic domain of DdPDE3 with DdPDE2 (RegA) and ten mammalian PDEs
All sequences are from published reports (GenBank2 accession nos U60170, U40370, U67733, M91667, U68532, AF043731, M27541, L12052, AF048837 and AB020593). Alignment was made
with the program ClustalW version 1.8, followed by improvements by hand. Positions where all 12 sequences are identical or conserved are depicted within a black box ; positions with 9–11 identical
or conserved amino acids are indicated by grey shading. Conserved amino acids are ILVM; STA ; DE ; NQ ; YFW ; KRH (single-letter codes). To improve the alignment, insertions of 44 and 47
residues in PDE3A and 60 amino acids in PDE1 relative to other PDEs have been deleted and are indicated by ‘ [44] ’, ‘ [47] ’ and ‘ [60] ’ respectively. The symbol i indicates amino acids that
are different in DdPDE3 relative to all other PDEs ; * and indicate two metal-binding sites. Open squares indicate amino acids that are conserved within the group of mammalian cAMP-specific
or cGMP-specific enzymes, but are different between the groups ; the filled squares indicate two amino acids that are conserved in all cAMP-specific enzymes, including DdPDE2. The y symbols
indicate amino acids that have been mutated in PDE5 [43] to investigate the specificity of substrate binding. Numbers indicate the amino acid positions in the complete proteins.
sequence is nearly identical with EST SSB116 but 50–200 bp
shorter than other EST clones identified subsequently. During
this project, genomic sequences became available in the Dictyo-
stelium genome-sequencing project that collectively spanned the
complete cDNA 116-6. Comparison of the genomic sequences
and the cDNA reveals the presence of two introns within the
catalytic domain (Figure 1). Conceptual translation of cDNA
116-6 reveals an open reading frame (ORF) of 522 amino acid
residues, predicting a protein of 60 kDa. The first in-frame
methionine residue is located at bp 286 and is preceded by stop
codons in all reading frames (Figure 1). A second in-frame
methionine is found at position 8. The nucleotide sequences
around these ATG codons both comply with the Dictyostelium
consensus sequence observed at the start codon for translation.
The N-terminal 200-residue part of the protein is very rich in
asparagine and glutamine residues, with two stretches of about
20 glutamine and 50 asparagine residues respectively, which are
interrupted sparsely by other amino acids. Many Dictyostelium
proteins contain polyglutamine or polyasparagine sequences of
unknown function. The putative catalytic domain of about 300
residues follows the N-terminal part of the protein. No other
sequence elements are discernible in this protein.
We were concerned about possible cloning artifacts, which we
have observed previously owing to the presence of polyasparagine
or polyglutamine repeats that are encoded by long stretches of
AAT and CAA respectively. It is conceivable that during cDNA
synthesis the fusion of two cDNA species occurred at such
stretches. This concern was fuelled by a 0.7 kb EST cDNA,
SSL142, that was identical at its 5« end with bp 71–594 of the full-
length cDNA 116-6 but showed no identity with DdPDE3 at its
3« end. Furthermore, we observed a deletion of eight AAT
codons in one of the genomic sequences. Unfortunately, none of
the genomic clones spanned the repeated sequences. The kZAP
cDNA 116-6 predicted restriction sites for ScaI and BglII at bp
24 and 1665 of the putative genomic sequence (see Figure 1).
Genomic DNA was digested with these enzymes. A Southern
blot revealed a band of the predicted size (results not shown).
Together with the observation that the cDNA and mRNA have
a comparable size, this suggests that the isolated full-length
cDNA was genuine and implies that the deduced protein did not
harbour clearly identifiable protein motifs other than the putative
catalytic domain. A composite nucleotide sequence assembled
from the currently known cDNA and genomic sequences is
presented in Figure 1.
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Figure 3 Family tree of PDE
With the use of the aligned sequences as presented in Figure 2 (not including the tree inserts),
a distance matrix was calculated by using ProtDist with Kimura’s approximation. Phylogenies
were estimated with the obtained distance matrix by using the Fitch program from the PHYLIP
package, version 3.5 [47]. The same results were obtained when the Dayhoff PAM matrix was
used instead of Kimura’s approximation to calculate the distance matrix, except for the location
of DdPDE2 relative to HsPDE7 and HsPDE2 (indicated by the broken line). A and G denote that
the enzyme hydrolyses cAMP and cGMP respectively.
Catalytic domain
Figure 2 shows an alignment of the putative catalytic domain of
DdPDE3 with Dictyostelium RegA (DdPDE2 [11,12]) and mam-
malian PDE enzymes [25–36]. The sequence identities found
within PDE families are also found in DdPDE3. For instance, of
40 residues that are identical or have conserved substitutions in
all other PDE enzymes, 38 are also present in DdPDE3. The
exceptions are the substitution of serine for a conserved as-
paragine residue at position 270, and of alanine for a conserved
glycine residue at position 315 of DdPDE3 (i in Figure 2). Two







served in PDEs are also observed in DdPDE3 [37].
A BLAST search with the putative catalytic domain of
DdPDE3 yields significant scores with several subtypes of PDE
from many organisms. At present, 10 PDE families have been
identified in mammals (PDE1–10) ; each family might display
several genes (types A, B, and so on) of which different splice
variants are known. The catalytic domains of PDE families show
an amino acid sequence identity of approx. 45%, whereas the
identity between members of one family is generally approx.
90%. To limit the discussion we compare DdPDE3 with human
type A PDE sequences only. DdPDE3 shows the highest simi-
larity with HsPDE9 (BLAST score 195), followed by Dictyo-
stelium DdPDE2 (score 169). The lowest identity (approx. 110) is
observed with HsPDE3 and HsPDE6, whereas the other PDEs
show an intermediate identity (BLAST score 130–150). By using
the alignment of the catalytic domains as presented in Figure 2,
we analysed the data with the Kumari method in ProtDis to
build a family tree composed of Dictyostelium and human PDE
sequences. Figure 3 reveals three subgroups of PDE enzymes.
One subgroup contains the cAMP-specific enzymes HsPDE4,
HsPDE7 and HsPDE8 and the dual-specificity enzymes HsPDE1
and HsPDE3. A second subgroup contains the cGMP-specific
enzymes HsPDE5 and HsPDE6 and the dual-specificity enzymes
HsPDE2 and HsPDE10. In the third group DdPDE3 is placed
together with the cAMP-specific DdPDE2 and the cGMP-specific
HsPDE9. The position and composition of the first two groups
are well defined by different methods (see the legend to Figure 3),
but the position of the third group relative to the other two
groups is less well defined; the Dayhoff method places DdPDE2
somewhat closer to HsPDE7 than does Kimura’s method. The
analysis indicates that there is no strict separation between
cAMP-specific, cGMP-specific and dual-specificity enzymes at
the amino acid level.
Expression of DdPDE3 catalytic domain in E. coli
The N-terminal 200 residues of DdPDE3 are composed nearly
exclusively of repeated Asn}Gln sequences that might cause
difficulties in expressing the protein in E. coli. Expression was
therefore started at residue 202, approx. 36 amino acids before
the putative catalytic domain of the enzyme. Lysates from
vector-control and DdPDE3-transformed E. coli cells were
assayed for PDE activity with [$H]cAMP or [$H]cGMP as a
substrate. DdPDE3 expression resulted in a moderate increase in
cAMP-hydrolytic activity (means‡S.D., nfl 3) from 0.94‡0.06
to 3.0‡0.4 pmol}min per mg of protein (Figure 4A). In contrast,
the hydrolysis of cGMP increased from a barely detectable
0.024‡0.04 pmol}min per mg in control lysates to as much as
50‡4 pmol}min per mg in lysates containing recombinant
DdPDE3. Thus the catalytic domain of DdPDE3 hydrolyses
cGMP approx. 25-fold faster than it hydrolyses cAMP, both at
10 nM substrate concentration. The specificity of DdPDE3 was
investigated further with competition experiments, showing that
increasing concentrations of unlabelled cGMP or cAMP inhibit
the hydrolysis of [$H]cGMP or [$H]cAMP (Figure 4B). Half-
maximal inhibition of the hydrolysis of 10 nM [$H]cGMP was
observed at 0.22 lM cGMP or 156 lM cAMP. Inhibition of the
hydrolysis of the less preferred substrate [$H]cAMP yielded
similar values, with half-maximal inhibition at 145 lM cAMP or
0.33 lM cGMP. Thus the catalytic domain of DdPDE3 binds
cGMP with approx. 650-fold higher affinity than cAMP. An
Eadie–Hofstee plot for the data on cGMP hydrolysis yielded a
linear curve (r#fl 0.99), indicating that the enzyme showed
normal Michaelis–Menten kinetics with a K
m
of 0.22 lM (Figure
4C).
Expression of DdPDE3 catalytic domain in Dictyostelium
The catalytic part of the enzyme was also expressed in Dictyo-
stelium by using the extrachromosomal plasmid HK12N. Lysates
were assayed in the presence of 5 mM dithiothreitol, which
inhibits psdA (DdPDE1) but not the DdPDE3 expressed in E.
coli. We also included 50 lM cAMP in the assay; at this
concentration the activity of DdPDE3 with [$H]cGMP as a
substrate was not inhibited (see Figure 4B), whereas the non-
specific DdPDE1 and the cAMP-specific DdPDE2 were inhibited
by more than 95% [12]. Under these assay conditions, lysates
from control cells exhibited significant hydrolysis of [$H]cGMP
(0.4 pmol}min per mg of protein). From previous experiments
we know that this activity is derived predominantly from a
cGMP-stimulated cGMP-specific PDE. Lysates from cells trans-
formed with DdPDE3 hydrolyse [$H]cGMP at a rate of
3.6 pmol}min per mg of protein, indicating a 9-fold increase in
cGMP-PDE activity. Thus the truncated C-terminal part of
DdPDE3 is also active in Dictyostelium.
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Figure 4 Substrate specificity of DdPDE3 expressed in E. coli
The putative catalytic domain (residues 202–522) was expressed in E. coli. Bacteria were lysed
and enzyme activity was measured with 10 nM [3H]cAMP or 10 nM [3H]cGMP. (A) PDE activity
of bacteria containing control vector (open bars) and bacteria expressing DdPDE3 (filled bars).
(B) Inhibition of PDE activity by cAMP (+,*) and cGMP (E,D) measured in lysates from
bacteria expressing DdPDE3 ; the reactions were performed with 10 nM [3H]cGMP (D,*) or
10 nM [3H]cAMP (E,+). (C) Eadie–Hofstee plot of cGMP hydrolysis by DdPDE expressed
in E. coli. The substrate concentrations used in this experiment were 0.01–3 lM cGMP.
Enzyme concentrations and incubation times were optimized to give no more than 25%
substrate conversion. (D) Inhibition of [3H]cGMP hydrolysis by DdPDE3 expressed in
Dictyostelium by cAMP (*) and cGMP (D). Error bars indicate S.D. of three experiments.
Measurements of [$H]cGMP hydrolysis at different concen-
trations of unlabelled cGMP or cAMP reveal that the catalytic
domain of DdPDE3 expressed in Dictyostelium has a similar
specificity to the catalytic domain of DdPDE3 expressed in E.
coli. Half-maximal inhibition occurs in Dictyostelium at 0.33 lM
cGMP or 207 lM cAMP, compared with 0.22 lM cGMP or
156 lM cAMP for the enzyme expressed in E. coli (Figure 4D).
Kinetic analysis of the data on cGMP hydrolysis yielded a linear
Eadie–Hofstee plot (r#fl 0.99; results not shown), suggesting
that the catalytic domain of DdPDE3 expressed in Dictyostelium
exhibits normal Michaelis–Menten kinetics.
DdPDE3 mRNA levels in wild-type Dictyostelium and mutant
StmF
To investigate the expression of DdPDE3, we isolated total
mRNA at different times during Dictyostelium development and
Figure 5 Northern blot of DdPDE3
mRNA was isolated from wild-type AX3 cells and mutant stmF strain NP368 at the
developmental times indicated, then size-fractionated and transferred to a Nytran filter. The blot
was probed with the catalytic domain of DdPDE3, detecting an mRNA with an estimated size
of approx. 1.9 kb.
Table 1 cGMP-hydrolysing activity of cells expressing the catalytic domain
of DdPDE3
PDE activity was measured with 10 nM [3H]cGMP in the absence or presence of 1 lM 8Br-
cGMP with lysates from E. coli or Dictyostelium cells. Results are means‡S.D. for three







E. coli control 0.24‡0.4 n.d. n.d.
E. coli DdPDE3 10.4‡0.9 9.0‡0.5 87‡9
Dictyostelium control 0.41‡0.08 1.35‡0.20 332‡84
Dictyostelium DdPDE3 3.59‡0.36 3.84‡0.50 107‡18
Dictyostelium stmF 0.12‡0.02 0.13‡0.03 106‡30
probed it with a DNA fragment encoding the catalytic domain of
DdPDE3 on Northern blots (Figure 5). The results reveal a
single band of 1.9 kb present at approximately constant levels
throughout development. The size of this band corresponds to
the length of the isolated 116-6 cDNA, which is presumed to be
full length. The Northern blot also reveals the transcription of
the DdPDE3 gene in stmF mutant NP368 and its isogenic
parental strain XP55. Mutant stmF lacks the cGMP-stimulated
cGMP-specific PDE activity, probably owing to a mutation in
the structural gene of this enzyme [38]. DdPDE3 seems to be
expressed at a normal level in mutant stmF. Furthermore, a
Southern blot of restriction-enzyme-digested DNA did not reveal
a marked difference between the DdPDE3 gene of wild-type cells
and stmF mutant cells (results not shown).
Although we cannot exclude point mutations, biochemical
results presented below suggest that DdPDE3 is expressed
unaltered in mutant stmF because the residual cGMP-PDE
activity in mutant stmF has all the characteristics of DdPDE3.
This suggests that DdPDE3 is distinct from the cGMP-stimulated
cGMP-PDE that is absent from mutant stmF.
PDE activity in wild-type and stmF mutant Dictyostelium cells
The hydrolysis of [$H]cGMP in mutant stmF was approx. 25%
of the activity in the isogenic wild-type strain XP55, measured at
10 nM [$H]cGMP (Table 1). The inhibition of [$H]cGMP hy-
drolysis by unlabelled cGMP and unlabelled cAMP was used to
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Figure 6 Hydrolysis of cGMP in wild-type XP55 and mutant stmF strains
PDE activity of XP55 (D,^) or stmF (E,_) was measured with 10 nM [3H]cGMP in the
presence of 5 mM dithiothreitol and 50 lM cAMP; different concentrations of cGMP (E,D)
or additional cAMP (_,^) were included as indicated. Arrows indicate concentrations giving
half-maximal inhibition. The results presented in the text on half-maximal inhibition by cAMP
take into account the 50 lM cAMP present in all incubations.
characterize the enzyme activities in stmF and wild-type XP55
(Figure 6). The addition of low concentrations of unlabelled
cGMP to the incubations of wild-type lysates resulted in an
increase in the hydrolysis of [$H]cGMP, whereas high cGMP
concentrations led to an inhibition of [$H]cGMP hydrolysis.
Analysis of these data yields an activation constant, K
a
, of
0.11 lM cGMP, a K
m
of 5.5 lM cGMP and a V
max
of 350
pmol}min per mg of protein for the activated enzyme. These
kinetic data are similar to those obtained previously for the
partly purified cGMP-stimulated cGMP-PDE from Dictyo-
stelium [39]. It was this cGMP-stimulated enzyme activity that
was shown to be absent from stmF mutant NP368 [14]. Indeed,
the residual cGMP-hydrolysing activity of stmF was not activated
by cGMP; low concentrations of unlabelled cGMP inhibited the
hydrolysis of [$H]cGMP (Figure 6). Kinetic analysis reveals
Michaelis–Menten kinetics with a K
m
of 0.27 lM cGMP and a
V
max
of 2.2 pmol}min per mg of protein. Inhibition of the
hydrolysis of [$H]cGMP by cAMP occurred only at high concen-
trations, both for the enzyme activity of XP55 and for that of
stmF cells, yielding half-maximal inhibition at 550 and 370 lM
cAMP respectively.
Regulation of DdPDE3 by 8Br-cGMP, bivalent cations and IBMX
Previous experiments have shown that the major cGMP-hydro-
lysing activity in Dictyostelium lysates is activated by cGMP with
a cyclic-nucleotide specificity that is different from the specificity
of hydrolysis [40]. For instance, 8-Br-cGMP is a potent activ-
ator of cGMP hydrolysis (K
a
fl 0.07 lM) but interacts poorly
with the catalytic site (K
i
fl 50 lM). The experiments presented
in Table 1 investigate the effect of 8Br-cGMP on [$H]cGMP hy-
drolysis. In lysates prepared from wild-type cells, 8Br-cGMP
stimulates cGMP-PDE activity approx. 3-fold. In contrast, 8Br-
cGMP does not alter the cGMP-hydrolysing activity of the
DdPDE3 catalytic domain expressed in E. coli or Dictyostelium.
This observation is consistent with the linear Michaelis–Menten
kinetics of DdPDE3. 8Br-cGMP also does not affect cGMP
hydrolysis by the residual PDE activity of stmF.
The amino acid sequence of DdPDE3 exhibits two putative
binding sites for bivalent metal ions. DdPDE3 expressed in E.
Figure 7 Activity of DdPDE3 in the presence of bivalent cations
Enzyme activity of the catalytic domain of DdPDE3 expressed in E. coli was measured with
10 nM [3H]cGMP in the presence of the indicated concentrations of MgCl2 (E), MnCl2 (D)
or CaCl2 (+) ; the control without bivalent cations contained 1 mM EDTA. The results are
presented relative to the activity with 1 mM MgCl2. Enzyme preparations of Dictyostelium wild-
type cells, Dictyostelium cells overexpressing DdPDE3 and Dictyostelium mutant stmF showed
a similar bivalent cation dependences. Error bars indicate S.D. of three experiments.
Figure 8 Effect of IBMX on DdPDE3
PDE activity was measured with 10 nM [3H]cGMP at different concentrations of IBMX by using
lysates of E. coli cells expressing the catalytic domain of DdPDE3 (E), Dictyostelium wild-type
cells (*), Dictyostelium cells overexpressing the catalytic domain of DdPDE3 (_) and
Dictyostelium mutant stmF cells (+). The results are presented relative to the activity without
IBMX ; see Table 1 for absolute activities. Error bars indicate S.D. of three experiments.
coli showed minimal activity in the absence of bivalent cations
(Figure 7). Increasing concentrations of Mg#+ enhanced the
activity, yielding maximal cGMP hydrolysis at 3–10 mM MgCl
#
.
Mn#+ was a more potent activator of DdPDE3 than Mg#+,
whereas Ca#+ did not enhance enzyme activity. This cation
specificity has been observed in other PDE enzymes, notably in
PDE9A [34], and is supported by the proposed two metal-
binding sites that have been deduced from the primary structure.
The cation specificity of cGMP hydrolysis by Dictyostelium
lysates is essentially identical with that of the catalytic domain of
DdPDE3 expressed in E. coli. This was observed for lysates
from wild-type cells, from DdPDE-overexpressing cells and from
mutant stmF cells (results not shown).
The effect of the PDE inhibitor IBMX on enzyme activity was
tested for the different enzyme preparations (Figure 8). IBMX
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Figure 9 Effect of DdPDE3 overexpression on cGMP levels in Dictyostelium
cells
After starvation for 5 h, cells were stimulated with 0.1 lM cAMP. At the times indicated,
samples were quenched in HClO4 and used to measure cGMP levels. (A) Wild-type HK12N cells
(D) and DdPDE3-overexpressing cells (E). (B) Cells overexpressing Dictyostelium guanylate
cyclase DdGCA (D) and DdGCA-overexpressing cells that also overexpressed DdPDE3 (E).
Error bars indicate S.E.M. of three to five experiments.
inhibited cGMP hydrolysis by the catalytic domain of DdPDE3
expressed in E. coli ; half maximal inhibition was obtained at
approx. 60 lM IBMX. Slightly higher IBMX concentrations
were needed to obtain the same inhibition of cGMP hydrolysis
by the catalytic domain of DdPDE3 overexpressed in Dictyo-
stelium. In contrast, cGMP hydrolysis in lysates prepared from
wild-type cells was poorly inhibited by IBMX, suggesting that
the cGMP-stimulated cGMP-PDE is relatively insensitive to
IBMX inhibition. Hydrolysis of cGMP by the residual activity of
mutant stmF seemed to be inhibited by IBMX with the same
sensitivity as exhibited by the activity of DdPDE3 overexpressed
in Dictyostelium (Figure 8).
Phenotype of DdPDE3-transformed Dictyostelium cells
Cells overexpressing the catalytic domain of DdPDE3 showed
normal cell aggregation and multicellular development (results
not shown). In addition, chemotaxis towards cAMP was not
significantly different from that of control cells. To evaluate these
observations, we measured basal and cAMP-stimulated cGMP
levels. In DdPDE3-overexpressing cells, basal cGMP levels were
reduced slightly from 3.44‡0.23 to 2.87‡0.11 pmol}10( cells
relative to control-transformed cells ; this difference is not stat-
istically significant (Figure 9A). The cAMP-mediated cGMP
response is significantly smaller in DdPDE3-overexpressing cells.
For a better understanding of the role of cGMP in Dictyostelium
we also overexpressed a Dictyostelium guanylate cyclase
(DdGCA) (J. Roelofs, H. Snippe, R. G. Kleineidam and P. J. M.
Van Haastert, unpublished work), resulting in an approx. 3-fold
elevation of basal cGMP levels (Figure 9B). When the catalytic
domain of DdPDE3 was overexpressed in these DdGCA-ex-
pressing cells, we observed a pronounced decrease in the cGMP
concentration to nearly the basal levels of wild-type cells, clearly
demonstrating that DdPDE3 is active in io. A cAMP-mediated
cGMP response was not observed in DdGCA-overexpressing
cells, possibly owing to the high constitutive guanylate cyclase
activity in these cells. The cAMP-mediated cGMP response
remained absent when DdPDE3 was also overexpressed in
DdGCA-expressing cells.
DISCUSSION
Spaciotemporal changes in intracellular cGMP levels might have
a crucial role in chemotactic signalling of Dictyostelium cells to
extracellular cAMP. It is therefore very important to thoroughly
characterize guanylate cyclase and cGMP-specific PDE activities
at a molecular level. As yet, not all cGMP-PDE activities are
accounted for in Dictyostelium. Here we characterize a cGMP-
specific PDE, DdPDE3, that is not activated by cGMP. This
PDE is the third PDE gene cloned in Dictyostelium, and the first
cGMP-specific enzyme cloned in lower eukaryotes.
DdPDE1, encoded by the psdA gene [41,42], is a glycoprotein
that is secreted or becomes localized on the cell surface. The
deduced amino acid sequence of DdPDE1 shows no sequence
similarity with other PDEs, suggesting that it evolved inde-
pendently from all other PDEs. The enzyme is inhibited by
dithiothreitol but not by IBMX or other compounds known to
inhibit mammalian PDEs. It hydrolyses cAMP and cGMP at
approximately the same rate with slight negative co-operativity
and an apparent K
m
of approx. 1 lM.
DdPDE2, encoded by the regA gene [11,12], was identified in
a genetic screen for suppressors of developmental mutants. The
deduced amino acid sequence predicts a protein with a response
regulatory domain and a PDE catalytic domain that shows
strong sequence similarity to that of mammalian PDEs. Enzyme
assays with the expressed protein demonstrate that DdPDE2 is a
cAMP-specific PDE with a K
m
of approx. 5 lM cAMP. IBMX
inhibits DdPDE2 with an IC
&!
of approx. 35 lM. The enzyme is
expressed throughout development, although at lower levels
during growth.
DdPDE3
DdPDE3 was identified through the Dictyostelium sequencing
projects. Cloning of the full-length cDNA and expression studies
of the putative catalytic domain characterize DdPDE3 as a
cGMP-specific PDE that is not activated by cGMP. The protein
consists merely of a C-terminal catalytic domain of approx. 300
amino acids connected to an N-terminal domain of approx.
200 amino acids predominantly harbouring polyglutamine and
polyasparagine stretches. No other protein sequence motifs could
be discerned. The catalytic domain of DdPDE3 shows a
high affinity for cGMP as a substrate, with a K
m
of 0.22 lM;
it is approx. 600-fold more specific for cGMP than for cAMP.
The enzyme requires bivalent cations for enzyme activity, with
a preference for Mn#+ over Mg#+, and is inhibited by IBMX
with an IC
&!
of approx. 60 lM.
Catalytic domain of DdPDE3
The catalytic domains of all PDE enzymes identified so far are
positioned at the C-terminus of the protein; regulatory elements,
when present, are located at the N-terminus. When comparing
the Dictyostelium DdPDE2 and DdPDE3 sequences with
ten human PDE sequences with the use of computer programs,
we noticed that the putative catalytic domains are well aligned up
to residue 653 in HsPDE4 (see Figure 2). Inspection by eye
clearly identified an additional conserved region that was not
previously recognized. This region ends at a conserved Trp and
is located just before the C-terminus of many PDE enzymes. In
HsPDE1 and HsPDE3 there is an insertion in this region of 60
and 47 residues respectively.
Multiple sequence alignment of the catalytic domains of
DdPDE2, DdPDE3 and HsPDE1–10 reveals two distinct groups
(HsPDE1, HsPDE3, HsPDE4, HsPDE7 and HsPDE8, and
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HsPDE2, HsPDE5, HsPDE6 and HsPDE10), and a third group
(HsPDE9 and DdPDE2}3) with less well defined branching
(Figure 3). The first group contains the cAMP-specific human
enzymes and two dual-specificity enzymes, whereas two cGMP-
specific enzymes are placed in the second group together with
twodual-specificity enzymes. It is possible that the dual-specificity
enzymes HsPDE1 and HsPDE3 evolved from or together with
the cAMP-specific enzymes and that HsPDE2 and HsPDE10
evolved from cGMP-specific enzymes.
The notion of the close relationship between PDEs that are
either cAMP-specific (DdPDE2) or cGMP-specific (HsPDE9
and DdPDE3) might help in the recognition of the amino acids
that provide substrate specificity. The sequence alignment of
the mammalian enzymes identifies seven amino acids that
are different between cAMP- and cGMP-specific PDEs but are
conserved within these groups (indicated by open squares in
Figure 2). However, on the inclusion of the Dictyostelium
DdPDE2 and DdPDE3 sequences in this analysis, none of the
seven amino acids remain conserved within the groups. For
example, the first potentially selective amino acid (at position 426
of HsPDE4) is histidine in mammalian cAMP-PDEs and arginine
in mammalian cGMP-PDEs; however, the cAMP-specific
DdPDE2 contains an arginine residue. In contrast, two amino
acids are conserved in all cAMP-specific enzymes and differ from
the cGMP-PDE or cGMP}cAMP-PDE isoenzymes: Asp and
Arg}Lys at positions 439 and 607 of HsPDE4 respectively (filled
square in Figure 2). However, in cGMP-specific enzymes no con-
served amino acids are present at these two positions.
Conversely, there is not a single amino acid that is conserved in
all cGMP-PDEs while differing from the amino acids of cAMP-
PDE at that position. A detailed mutagenesis study on substrate
specificity has been performed with the cGMP-specific PDE5
[43]. Four amino acids were selected based on hydropathy
calculations (indicated by y in Figure 2). Conversion of these
amino acids into the residues present in the cAMP-specific
HsPDE4 (from Trp, Gln, Ala and Leu to Leu, Tyr, Thr and Arg
respectively) changed the specificity approx. 100-fold towards
cAMP. Interestingly, none of these amino acids are conserved
within the group of cAMP-specific or cGMP-specific PDEs.
Apparently, substrate specificity in PDEs is not determined by
absolutely conserved amino acids. This situation is different from
other nucleotide-binding proteins. For instance, in cAMP-de-
pendent and cGMP-dependent protein kinases, specificity is
dominated by a conserved Ala and Thr residue respectively [44].
In adenylate and guanylate cyclases, two amino acids determine
substrate specificity, Lys and Asp binding ATP, and Glu and Cys
binding GTP [45,46].
Function of DdPDE3 in vivo
The cGMP-PDE activity in wild-type Dictyostelium lysates is
characterized by non-Michaelis–Menten kinetics involving an
enzyme that is activated by cGMP. This enzyme has been partly
purified and is absent from mutant stmF [14]. The genetic





for IBMX) properties of the catalytic domain of
DdPDE3, suggest that DdPDE3 is not identical with the cGMP-
stimulated cGMP-PDE. This would imply that the Dictyostelium
genome still contains at least one other PDE. The Dictyo-
stelium sequencing project does not yet provide convincing evi-
dence for the existence of a fourth PDE gene. At present the
chance of finding a gene with 1 kb of coding sequence (300-
residue PDE catalytic domain) is approx. 80–90%.
The cGMP-PDE activity in mutant stmF is approx. 25% of
the cGMP-hydrolysing activity of wild-type cells, both measured
at low cGMP concentrations. At higher substrate concentrations
the contribution of DdPDE3 to cGMP hydrolysis in io
diminished owing to its high affinity but relatively low V
max
compared with the cGMP-stimulated PDE. The moderate im-
portance of DdPDE3 in the hydrolysis of cGMP in io is also
demonstrated on overexpression of the enzyme in Dictyostelium
cells. When the catalytic domain of DdPDE3 is overexpressed
approx. 25-fold comparedwith the endogenous levels ofDdPDE3
in wild-type cells, this results in a non-significant decrease in
basal cGMP levels and a 33% decrease in the cAMP-mediated
cGMP response. Overexpression of the catalytic domain of
DdPDE3 in cells that also overexpress guanylate cyclase DdGCA
has a more pronounced effect. The approx. 3-fold increase in
cGMP levels owing to DdGCA overexpression is decreased by
DdPDE3 to nearly the basal cGMP levels of wild-type cells.
These combined results suggest that DdPDE3 is involved mainly
in regulating basal cGMP levels and has no predominant role in
hydrolysing cGMP that is synthesized on receptor stimulation.
This conclusion is supported by the lack of an overt phenotype
of the DdPDE3-overexpressing cells.
In summary, we have identified a high-affinity cGMP-specific
PDE in Dictyostelium that shows similarity to mammalian PDE9,
in both its biochemical properties and its amino acid sequence.
The enzyme contributes at most 30% to the hydrolysis of
intracellular cGMP; the remainder is contributed by a cGMP-
stimulated cGMP-PDE that is absent from mutant stmF. Identi-
fication and isolation of the gene encoding the latter enzyme will
provide the means of full control of cGMP levels in Dictyostelium
and of establishing the function of cGMP in this organism.
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